EQ9-56075-73847
2 vaccinations
2 coded responses
12 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 211 / MD
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Migraine, Pregnancy — Feeling: Fair · Headache · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I feel this migraine (classical + aura .... persisting into splitting HA) is likely a symptom of pregnancy, as I had a similar situation at about 34 weeks with my first baby as well)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-28
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Delivery, Incontinence — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Stress incontinence s/p vaginal deliveryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-14
-
2021-04-14
Call successfulDoes not wish to fill out VAERS report
- 2022-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): I feel this migraine (classical + aura .... persisting into splitting HA) is likely a symptom of pregnancy, as I had a similar situation at about 34 weeks with my first baby as well)
Release 7 — 3 months, dose 2
Symptoms: Stress incontinence s/p vaginal delivery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | ✓ | ✓ | ✓ |
| SD | Incontinence | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release